Based
AUSTIN, TEXAS
AUSTIN, TEXAS
Year formed
2024
2024
Industry group
Biotechnology
Biotechnology
Filings
5
5
Raised (new offerings)
$11.05M
$11.05M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-08-07 | New offering first sale 2026-06-05 | $3M | $3M | details · SEC filing |
| 2026-08-06 | New offering first sale 2026-03-10 | $3M | $3M | SEC filing |
| 2026-08-06 | New offering first sale 2025-08-19 | $250K | $250K | SEC filing |
| 2026-08-06 | New offering first sale 2025-08-18 | $250K | $250K | SEC filing |
| 2026-07-23 | New offering first sale 2025-04-01 | $4.55M | $4.55M | SEC filing |
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from BioGene Therapeutics Inc.'s own filings with the SEC. The people those filings name are on the team page.